title: Lesion detectability on diffusion-weighted imaging in transient global amnesia: the influence of imaging timing and magnetic field strength.
abstract: BACKGROUND
  Transient global amnesia (TGA) is a benign disease with a sudden-onset, transient memory disturbance. Characteristic punctate high-signal intensity lesions in the hippocampus on diffusion-weighted imaging (DWI) have been reported in variable frequencies. We investigated the influence of the timing of DWI and the magnetic field strength on the lesion detectability in TGA.
  
  
  METHODS
  Seventy-three patients diagnosed with TGA underwent DWI within 24 h after the symptom onset and again on day 3 at either 1.5 (n = 31) or 3 T (n = 42). The patients were divided into three subgroups according to the time lapse after the symptom onset to the first DWI (0-6 h, 6-12 h, and 12-24 h).
  
  
  RESULTS
  The detection rate of the lesions during the first 24 h rose statistically significantly with increased time lapse after the symptom onset (34% in 0-6 h, 62% in 6-12 h, and 67% in 12-24 h). It increased up to 75% on day 3. The detection rate was higher at 3 T than at 1.5 T in all time points (41% vs. 27% in 0-6 h, 70% vs. 44% in 6-12 h, 80% vs. 57% in 12-24 h, and 86% vs. 61% on day 3), but the statistical significance was achieved only on day 3.
  
  
  CONCLUSIONS
  Awareness of the different lesion detectability on DWI according to the time lapse after the symptom onset can help in diagnosing the patients with suspected TGA. High field strength is another important factor to increase the lesion detectability on DWI.
authors: Department of Radiology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 166 Gumiro, Bundang-gu, Seongnam-si 463-707, South Korea.
authors: Inseon
authors: I
authors: Ryoo
authors: Jae Hyoung
authors: JH
authors: Kim
authors: Sangyun
authors: S
authors: Kim
authors: Byung Se
authors: BS
authors: Choi
authors: Cheolkyu
authors: C
authors: Jung
authors: Sung Il
authors: SI
authors: Hwang
references: Stroke. 1999 Oct;30(10):2070-2
references: 10512909
references: Stroke. 1995 Sep;26(9):1536-42
references: 7660394
references: Brain. 1990 Jun;113 ( Pt 3):639-57
references: 2194627
references: Brain. 1990 Feb;113 ( Pt 1):1-25
references: 2302527
references: J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):438-41
references: 15716545
references: Neurology. 1987 May;37(5):733-7
references: 3574671
references: AJNR Am J Neuroradiol. 2006 Sep;27(8):1794-8
references: 16971638
references: Neurology. 2004 Jun 22;62(12):2165-70
references: 15210876
references: J Med Lyon. 1956 Oct 5;37(882):697-701
references: 13377072
references: Brain. 2006 Jul;129(Pt 7):1640-58
references: 16670178
references: J Neurosci. 2005 Apr 27;25(17):4288-93
references: 15858055
references: Neurology. 2005 Apr 12;64(7):1170-4
references: 15824342
references: Neuroradiology. 2007 Jun;49(6):481-7
references: 17522744
references: Prog Brain Res. 2008;169:145-58
references: 18394472
references: Epilepsia. 2009 Apr;50(4):586-97
references: 19054412
references: Brain. 2006 Nov;129(Pt 11):2874-84
references: 17003071
references: Eur Radiol. 2006 Sep;16(9):2067-73
references: 16649033
references: Acta Neurol Scand Suppl. 1964;40:SUPPL 9:1-83
references: 14198929
references: Ann Neurol. 1998 Feb;43(2):164-70
references: 9485057
references: Ann Neurol. 2007 Jun;61(6):587-98
references: 17444534
references: Swiss Med Wkly. 2009 May 16;139(19-20):288-92
references: 19452291
references: Lancet Neurol. 2005 Jul;4(7):437-44
references: 15963447
references: Invest Radiol. 2003 Jul;38(7):415-22
references: 12821855
references: J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):1002-4
references: 8057091
references: Lancet Neurol. 2010 Feb;9(2):205-14
references: 20129169
references: AJNR Am J Neuroradiol. 2008 Aug;29(7):1324-8
references: 18451087
references: Stroke. 2009 Jun;40(6):2042-5
references: 19359650
references: Yonsei Med J. 2009 Apr 30;50(2):211-4
references: 19430553